(Reuters) – Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for…
Germany’s energy crisis powers hydrogen switch
By Louisa Off and Riham Alkousaa KELHEIM, Germany (Reuters) – From the moment Russian gas exports to Germany were first…
Dollar slides as traders weigh China outlook, U.S. jobless claims
By Hannah Lang WASHINGTON (Reuters) – The dollar slipped on Thursday with investors on edge at the end of the…
Ecuador insecurity, drug crime hitting exporters -business group
GUAYAQUIL (Reuters) – Insecurity in Ecuador is hurting the Andean country’s exports of products like bananas and shrimp, an exporters…
U.S. sues AmerisourceBergen, says distributor helped ignite opioid epidemic
By Nate Raymond, Jonathan Stempel and Gram Slattery WASHINGTON (Reuters) -The U.S. government on Thursday filed a lawsuit accusing AmerisourceBergen…
Southwest Airlines plans to return to normal operations on Friday
(Reuters) – Southwest Airlines Co plans to return to normal operations with minimal disruptions on Friday, the carrier said on…
European shares rise; China’s COVID surge quells risk appetite
By Bansari Mayur Kamdar and Shreyashi Sanyal (Reuters) – European shares closed higher on Thursday, with technology stocks leading gains,…
Jobless benefits rolls grow but U.S. labor market remains resilient
By Dan Burns (Reuters) -The number of Americans filing new claims for unemployment benefits edged higher last week and a…
Honda to recall 200,000 hybrid vehicles made in China -regulator
By Casey Hall SHANGHAI (Reuters) – Honda will recall just over 200,000 hybrid vehicles due to issues with brake pedal…
Italy says goal in exiting MPS is having several big banks
By Valentina Za and Giuseppe Fonte MILAN (Reuters) -Italy will work to exit the capital of bailed-out lender Monte dei…